At a glance
- Originator Sanofi Winthrop
- Class Analgesics
- Mechanism of Action Neurokinin 1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 31 Aug 1998 No-Development-Reported for Pain in USA (Unknown route)
- 22 Apr 1996 Preclinical development for Pain in USA (Unknown route)